BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 9640603)

  • 1. The frequency of fragile X syndrome among selected patients at Songklanagarind Hospital during 1991-1996, studied by cytogenetic and molecular methods.
    Jinorose U; Vasiknanonte P; Limprasert P; Brown WT; Panich V
    Southeast Asian J Trop Med Public Health; 1997; 28 Suppl 3():69-74. PubMed ID: 9640603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular pathology of the fragile X syndrome.
    Tsongalis GJ; Silverman LM
    Arch Pathol Lab Med; 1993 Nov; 117(11):1121-5. PubMed ID: 8239933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiplex methylation specific PCR analysis of fragile X syndrome: experience in Songklanagarind Hospital.
    Charalsawadi C; Sripo T; Limprasert P
    J Med Assoc Thai; 2005 Aug; 88(8):1057-61. PubMed ID: 16404832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Detection of FMR-1 gene expression by RT-PCR].
    Zheng L; Fan Y; Huang T; Zhu N; Shen Y; Wu G
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1995 Dec; 17(6):407-11. PubMed ID: 9208564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular screening for fragile X syndrome in Thailand.
    Limprasert P; Ruangdaraganon N; Sura T; Vasiknanonte P; Jinorose U
    Southeast Asian J Trop Med Public Health; 1999; 30 Suppl 2():114-8. PubMed ID: 11400746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A survey of fragile X syndrome in a sample from Spanish Basque country.
    Arrieta I; Criado B; Martinez B; Telez M; Nuñez T; Peñagarikano O; Ortega B; Lostao CM
    Ann Genet; 1999; 42(4):197-201. PubMed ID: 10674158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A genetic and molecular study of 85 families affected with the fragile X syndrome].
    Milà Recasens M; Sánchez Díaz A; Glover López G; Castellví Bel S; Carbonell Meseguer P; Kruyer H; Ballesta Martínez F; Estivill Pallejà X
    An Esp Pediatr; 1996 Mar; 44(3):250-6. PubMed ID: 8830601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of pre-mutation of X chromosome CGG trinucleotide repeats on brain anatomy.
    Moore CJ; Daly EM; Tassone F; Tysoe C; Schmitz N; Ng V; Chitnis X; McGuire P; Suckling J; Davies KE; Hagerman RJ; Hagerman PJ; Murphy KC; Murphy DG
    Brain; 2004 Dec; 127(Pt 12):2672-81. PubMed ID: 15483045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A methylation PCR approach for detection of fragile X syndrome.
    Panagopoulos I; Lassen C; Kristoffersson U; Aman P
    Hum Mutat; 1999; 14(1):71-9. PubMed ID: 10447261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of CGG variation through 642 meioses in Fragile X families.
    Rifé M; Badenas C; Quintó L; Puigoriol E; Tazón B; Rodriguez-Revenga L; Jiménez L; Sánchez A; Milà M
    Mol Hum Reprod; 2004 Oct; 10(10):773-6. PubMed ID: 15322225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequency of Fra X syndrome among institutionalized mentally retarded males in Poland.
    Mazurczak T; Bocian E; Milewski M; Obersztyn E; Stańczak H; Bal J; Szamotulska K; Karwacki MW
    Am J Med Genet; 1996 Jul; 64(1):184-6. PubMed ID: 8826472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fragile X mental retardation syndrome: from pathogenesis to diagnostic issues.
    Mandel JL; Biancalana V
    Growth Horm IGF Res; 2004 Jun; 14 Suppl A():S158-65. PubMed ID: 15135801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical and molecular screening for fragile X syndrome in 300 patients with non-specific mental retardation].
    Jara L; López M; Mellado C; Aspillaga M; Avendaño I; Blanco R
    Rev Med Chil; 1998 Aug; 126(8):911-8. PubMed ID: 9830742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fragile X syndrome.
    Laxova R
    Adv Pediatr; 1994; 41():305-42. PubMed ID: 7992687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and instability of fragile X alleles: implications for offering fragile X prenatal diagnosis.
    Cronister A; Teicher J; Rohlfs EM; Donnenfeld A; Hallam S
    Obstet Gynecol; 2008 Mar; 111(3):596-601. PubMed ID: 18310361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular diagnosis and genetic counseling for fragile X mental retardation.
    Pandey UB; Phadke SR; Mittal B
    Neurol India; 2004 Mar; 52(1):36-42. PubMed ID: 15069237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fragile-X syndrome in east Finland: molecular approach to genetic and prenatal diagnosis.
    Ryynänen M; Pulkkinen L; Kirkinen P; Saarikoski S
    Am J Med Genet; 1994 Jul; 51(4):463-5. PubMed ID: 7943020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 10 years' experience in fragile X testing among mentally retarded individuals in Greece: a molecular and epidemiological approach.
    Sofocleous C; Kitsiou S; Fryssira H; Kolialexi A; Kalaitzidaki M; Roma E; Tsangaris GT; Chistofidou C; Metaxotou C; Kanavakis E; Mavrou A
    In Vivo; 2008; 22(4):451-5. PubMed ID: 18712171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of a clinical checklist in the diagnosis of fragile X syndrome in India.
    Guruju MR; Lavanya K; Thelma BK; Sujatha M; OmSai VR; Nagarathna V; Amarjyothi P; Jyothi A; Anandaraj MP
    J Clin Neurosci; 2009 Oct; 16(10):1305-10. PubMed ID: 19560928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A neuropsychological investigation of male premutation carriers of fragile X syndrome.
    Moore CJ; Daly EM; Schmitz N; Tassone F; Tysoe C; Hagerman RJ; Hagerman PJ; Morris RG; Murphy KC; Murphy DG
    Neuropsychologia; 2004; 42(14):1934-47. PubMed ID: 15381024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.